Health Newstrack

Track health news daily at


Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that…

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled…

The U.S. Food and Drug Administration recently approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous…


Homeopathy Software
White Box Theme : Skin: Blue Majestic | Version: 23.31 | Second: 0.542 | Queries: 89 | Server load: 1.2 | 2015-11-26 12:24:30
Alexa Traffic Rank - Global: 472520 | India: 65096     Google PageRank - 3